title: Letter to the editor. Probing gender-specific change in IgG1 Fc-galactosylation in non-small cell lung cancer patients treated with epidermal growth factor receptor inhibitor.
authors.forename: Guoqiang
authors.initials: G
authors.lastname: Chen
authors.forename: Li
authors.initials: L
authors.lastname: Zhang
authors.forename: Yanying
authors.initials: Y
authors.lastname: Wang
authors.forename: Yumei
authors.initials: Y
authors.lastname: Guo
authors.forename: Hui
authors.initials: H
authors.lastname: Liu
authors.forename: Zhili
authors.initials: Z
authors.lastname: Li
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy / Q000276:immunology*; D043844:Crown Ethers / Q000627:therapeutic use*; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D005260:Female; D005690:Galactose; D006801:Humans; D007141:Immunoglobulin Fc Fragments / Q000737:chemistry; D007074:Immunoglobulin G / Q000737:chemistry*; D008175:Lung Neoplasms / Q000188:drug therapy / Q000276:immunology*; D008297:Male; D013058:Mass Spectrometry / Q000379:methods; D011799:Quinazolines / Q000627:therapeutic use*; D012737:Sex Factors
chemical_list: D043844:Crown Ethers; D007141:Immunoglobulin Fc Fragments; D007074:Immunoglobulin G; D011799:Quinazolines; C531470:icotinib; D066246:ErbB Receptors; D005690:Galactose